Bruncsics, Bence
Hullam, Gabor
Bolgar, Bence
Petschner, Peter
Millinghoffer, Andras
Gecse, Kinga
Eszlari, Nora
Gonda, Xenia
Jones, Debra J.
Burden, Sorrel T.
Antal, Peter
Deakin, Bill
Bagdy, Gyorgy
Juhasz, Gabriella
Funding for this research was provided by:
NRDI Fund based on the charter of bolster issued by the NRDI Office under the auspices of the Ministry for Innovation and Technology (BME NC TKP2020, BME IE-BIO TKP2020, Artificial Intelligence National Laboratory Programme)
National Research, Development, and Innovation Fund of Hungary (TKP2021-EGA-02)
National Research, Development and Innovation Office, Hungary (OTKA 139330)
Ministry of Innovation and the National Research, Development and Innovation Office within the framework of the Artificial Intelligence National Laboratory Programme
New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund (ÚNKP-21-5-BME-362, ÚNKP-21-4-II-BME-143, ÚNKP-22-3-II-SE-27, ÚNKP-22-4-II-SE-1)
National Research, Development and Innovation Office, Hungary , under the frame of ERA PerMed (ERAPERMED2019-108, ERAPERMED2019-108, ERAPERMED2019-108, ERAPERMED2019-108)
Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences
Hungarian Brain Research Program (2017-1.2.1-NKP-2017-00002, NAP2022-I-4/2022, 2017-1.2.1-NKP-2017-00002, 2017-1.2.1-NKP-2017-00002, 2017-1.2.1-NKP-2017-00002, 2017-1.2.1-NKP-2017-00002)
Japan Society for the Promotion of Science (P20809)
Thematic Excellence Programme, Ministry of Innovation and Technology in Hungary, from the National Research, Development and Innovation Fund (TKP2021-EGA-25)
National Institute for Health Research Manchester Biomedical Research Centre
Semmelweis University
Article History
Received: 29 May 2022
Accepted: 13 March 2023
First Online: 27 March 2023
Competing interests
: Gyorgy Bagdy is a member of the Board of directors at Gedeon Richter. Bill Deakin has share options in P1vital, and he has performed research, consultancy, and speaking engagements for AstraZeneca, Autifony, Bristol-Myers Squibb, Eli Lilly, Janssen-Cilag, P1vital, Schering Plough, and Servier, for which all fees have been paid to the University of Manchester to reimburse them for the time taken. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. The remaining authors declare no conflict of interest.